Showing results (1211-1220 of 1,861) with videos related to

Sort By:
Pageof 187
Neuropeptides|November 14, 2017
Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral densityK L Seldeen, P G Halley, C H Volmar, et al.
Tropical Diseases, Travel Medicine and Vaccines|September 9, 2017
World Rabies Day campaign in the PhilippinesDanellie Joy O Medina, Sarah I Jayme, Anna Charinna B Amparo, et al.
Hardwarex|September 24, 2024
BioSense: An automated sensing node for organismal and environmental biologyAndrea Contina, Eric Abelson, Brendan Allison, et al.
The Journal of Surgical Research|November 23, 2024
Sex and Race/Ethnicity Based Trends in Matriculation to General Surgery Residency and Associated Fellowship ProgramsAreeba Saif, A Leila Sarvestani, Martha E Teke, et al.
Journal of Veterinary Internal Medicine|December 5, 2018
Comparison of the performance of the IDEXX SediVue Dx® with manual microscopy for the detection of cells and 2 crystal types in canine and feline urineAnnalisa M Hernandez, Graham E A Bilbrough, Dennis B DeNicola, et al.
Annals of Surgical Oncology|November 8, 2022
Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical TrialsBenjamin L Green, Alisa N Blumenthaler, Lauren A Gamble, et al.
Annals of Surgical Oncology|April 24, 2019
A Survey of the Complex General Surgical Oncology Fellowship Programs Regarding Applicant Selection and RankMichael M Wach, Reed I Ayabe, Samantha M Ruff, et al.
Biomedical Chromatography : BMC|August 16, 2018
Development of a simple HPLC-DAD multi-analyte procedure and its application in cases evaluated by the Poison Control Center of São Paulo, BrazilSarah C W S E Franco de Oliveira, Alexandre D Zucoloto, Carolina D R de Oliveira, et al.
Annals of Surgery|August 3, 2017
Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ AdenocarcinomaJonathan M Hernandez, Volkan Beylergil, Debra A Goldman, et al.
The Journal of Prevention of Alzheimer'S Disease|January 7, 2026
Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's diseaseJames W Kupiec, Anton P Porsteinsson, Raymond S Turner, et al.
Pageof 187